Ah. Harilasaari et al., BRAIN PERFUSION AFTER TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, The Journal of nuclear medicine, 38(1), 1997, pp. 82-88
Children with acute lymphoblastic leukemia (ALL) have impairment in th
eir neuropsychological functioning and morphological changes in their
brain after cranial irradiation and chemotherapy. The aim of this stud
y was to identify possible brain perfusion defects caused by different
types of treatment and their association with abnormalities in cerebr
al MRI and neuropsychological and clinical neurological findings, Meth
ods: Twenty-five consecutive children with ALL at the cessation of che
motherapy or after 1 yr were included. All of the children were given
intravenous and intrathecal methotrexate for central nervous system th
erapy, 13 of them received cranial radiation therapy, Brain SPECT, cer
ebral MRI, clinical neurological and neuropsychological evaluations we
re performed, Results: Eleven of the 25 patients (44%) had brain perfu
sion defects in SPECT, eight of whom were treated with chemotherapy al
one, and three received cranial irradiation, Two patients had small bi
lateral white matter changes on MRI; their brain SPECT scans were abno
rmal, although the findings were not related. Impairment of neuropsych
ological functioning was found in 86% of the patients tested, No signi
ficant difference between the patients with abnormal and normal SPECT
were found, Those patients with abnormal SPECT were younger than those
with normal SPECT and had received more frequent intravenous methotre
xate infusions, Conclusion: Brain SPECT detected perfusion defects tha
t had occurred after treatment for childhood ALL. These defects may be
related to frequent administration of a combination of intravenous an
d intrathecal methotrexate and/or young age.